Cargando…
Modifiable contributing factors to COVID-19: A comprehensive review
The devastating complications of coronavirus disease 2019 (COVID-19) result from an individual's dysfunctional immune response following the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple toxic stressors and behaviors contribute to underlying immune sys...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701571/ https://www.ncbi.nlm.nih.gov/pubmed/36450305 http://dx.doi.org/10.1016/j.fct.2022.113511 |
_version_ | 1784839562701307904 |
---|---|
author | Kostoff, Ronald Neil Briggs, Michael Brandon Kanduc, Darja Dewanjee, Saikat Kandimalla, Ramesh Shoenfeld, Yehuda Porter, Alan L. Tsatsakis, Aristidis |
author_facet | Kostoff, Ronald Neil Briggs, Michael Brandon Kanduc, Darja Dewanjee, Saikat Kandimalla, Ramesh Shoenfeld, Yehuda Porter, Alan L. Tsatsakis, Aristidis |
author_sort | Kostoff, Ronald Neil |
collection | PubMed |
description | The devastating complications of coronavirus disease 2019 (COVID-19) result from an individual's dysfunctional immune response following the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple toxic stressors and behaviors contribute to underlying immune system dysfunction. SARS-CoV-2 exploits the dysfunctional immune system to trigger a chain of events ultimately leading to COVID-19. The current study identifies eighty immune system dysfunction-enabling toxic stressors and behaviors (hereafter called modifiable contributing factors (CFs)) that also link directly to COVID-19. Each CF is assigned to one of the five categories in the CF taxonomy shown in Section 3.3.: Lifestyle (e.g., diet, substance abuse); Iatrogenic (e.g., drugs, surgery); Biotoxins (e.g., micro-organisms, mycotoxins); Occupational/Environmental (e.g., heavy metals, pesticides); Psychosocial/Socioeconomic (e.g., chronic stress, lower education). The current study shows how each modifiable factor contributes to decreased immune system capability, increased inflammation and coagulation, and increased neural damage and neurodegeneration. It is unclear how real progress can be made in combatting COVID-19 and other similar diseases caused by viral variants without addressing and eliminating these modifiable CFs. |
format | Online Article Text |
id | pubmed-9701571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97015712022-11-28 Modifiable contributing factors to COVID-19: A comprehensive review Kostoff, Ronald Neil Briggs, Michael Brandon Kanduc, Darja Dewanjee, Saikat Kandimalla, Ramesh Shoenfeld, Yehuda Porter, Alan L. Tsatsakis, Aristidis Food Chem Toxicol Review The devastating complications of coronavirus disease 2019 (COVID-19) result from an individual's dysfunctional immune response following the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple toxic stressors and behaviors contribute to underlying immune system dysfunction. SARS-CoV-2 exploits the dysfunctional immune system to trigger a chain of events ultimately leading to COVID-19. The current study identifies eighty immune system dysfunction-enabling toxic stressors and behaviors (hereafter called modifiable contributing factors (CFs)) that also link directly to COVID-19. Each CF is assigned to one of the five categories in the CF taxonomy shown in Section 3.3.: Lifestyle (e.g., diet, substance abuse); Iatrogenic (e.g., drugs, surgery); Biotoxins (e.g., micro-organisms, mycotoxins); Occupational/Environmental (e.g., heavy metals, pesticides); Psychosocial/Socioeconomic (e.g., chronic stress, lower education). The current study shows how each modifiable factor contributes to decreased immune system capability, increased inflammation and coagulation, and increased neural damage and neurodegeneration. It is unclear how real progress can be made in combatting COVID-19 and other similar diseases caused by viral variants without addressing and eliminating these modifiable CFs. Elsevier Ltd. 2023-01 2022-11-28 /pmc/articles/PMC9701571/ /pubmed/36450305 http://dx.doi.org/10.1016/j.fct.2022.113511 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Kostoff, Ronald Neil Briggs, Michael Brandon Kanduc, Darja Dewanjee, Saikat Kandimalla, Ramesh Shoenfeld, Yehuda Porter, Alan L. Tsatsakis, Aristidis Modifiable contributing factors to COVID-19: A comprehensive review |
title | Modifiable contributing factors to COVID-19: A comprehensive review |
title_full | Modifiable contributing factors to COVID-19: A comprehensive review |
title_fullStr | Modifiable contributing factors to COVID-19: A comprehensive review |
title_full_unstemmed | Modifiable contributing factors to COVID-19: A comprehensive review |
title_short | Modifiable contributing factors to COVID-19: A comprehensive review |
title_sort | modifiable contributing factors to covid-19: a comprehensive review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701571/ https://www.ncbi.nlm.nih.gov/pubmed/36450305 http://dx.doi.org/10.1016/j.fct.2022.113511 |
work_keys_str_mv | AT kostoffronaldneil modifiablecontributingfactorstocovid19acomprehensivereview AT briggsmichaelbrandon modifiablecontributingfactorstocovid19acomprehensivereview AT kanducdarja modifiablecontributingfactorstocovid19acomprehensivereview AT dewanjeesaikat modifiablecontributingfactorstocovid19acomprehensivereview AT kandimallaramesh modifiablecontributingfactorstocovid19acomprehensivereview AT shoenfeldyehuda modifiablecontributingfactorstocovid19acomprehensivereview AT porteralanl modifiablecontributingfactorstocovid19acomprehensivereview AT tsatsakisaristidis modifiablecontributingfactorstocovid19acomprehensivereview |